Verition Fund Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
LA
LP
MF
AA
PAMP
SCM
RCM
TCM
AIMCA
Verition Fund Management's TDACW Position: Q2 2026 in Review
Verition Fund Management reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 57% in Q2 2026, selling an estimated $257K and leaving 191,700 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #1789.
Verition Fund Management first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.
- Verition Fund Management held 191,700 shares of Translational Development Acquisition Corp Warrants worth $253K as of Q2 2026.
- Verition Fund Management sold 256,295 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $257K.
- Translational Development Acquisition Corp Warrants made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1789 holding.
- Verition Fund Management first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
- 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.